financetom
Business
financetom
/
Business
/
Soccer-Moyes jealous of big-spending teams while Everton's hands are tied
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Soccer-Moyes jealous of big-spending teams while Everton's hands are tied
Jan 31, 2025 8:40 AM

Jan 31 (Reuters) - Everton can only look on in envy at other clubs chasing big-money signings before the mid-season transfer window closes as they cannot afford to fall foul of the Premier League's financial rules again, manager David Moyes said on Friday.

Everton are in desperate need of reinforcements as they look to avoid relegation once again after they lost Orel Mangala for the season due to a knee injury while striker Dominic Calvert-Lewin is sidelined for a few weeks with a hamstring issue.

Dwight McNeil is nursing a knee injury while Armando Broja is also sidelined as Everton look for reinforcements, but Moyes does not want the club to be deducted points again for breaching Profitability and Sustainability Rules (PSR).

Everton were docked eight points last season for PSR breaches but managed to avoid relegation by finishing 15th. The Merseyside club are 16th this season, seven points from the drop zone.

"Confidence at the moment has become difficult because it's certainly not for the want of trying (in the market). I know behind the scenes... we are really out there trying to find players we can bring in," Moyes told reporters.

"Ultimately we are still hampered by PSR. I'm really jealous of watching a lot of teams who can maybe go for a lot of players at expensive prices.

"At the moment we're not quite there but we don't want to get ourselves in a position we've been in before with points deductions. I hope the supporters all understand that and go with us."

The transfer window closes on Monday and Moyes said they hope to bring in new recruits, but that they may not be their top targets if the club had more money to spend.

With Beto the only striker available to Moyes, the Scottish manager said he would consider playing centre back Michael Keane up front if he was out of options against Leicester City on Saturday.

"Let's be fair, he's not a centre forward but everyone seems to tell me he's always done quite well," Moyes said.

"I remember him from years ago and he played very well for Burnley before he came here and when I was at Manchester United I had him for a while. I do think we are probably going to try anything.

"We are going to need everybody to be adaptable and flexible and see what possibilities we've got. It's not my first thought, but I might need it."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BridgeBio Pharma Reports Positive Additional Data From Phase 3 Study of Acoramidis; Shares Rise
BridgeBio Pharma Reports Positive Additional Data From Phase 3 Study of Acoramidis; Shares Rise
Sep 1, 2024
12:02 PM EDT, 08/30/2024 (MT Newswires) -- BridgeBio Pharma ( BBIO ) said Friday that additional data from a phase 3 study of acoramidis in transthyretin amyloid cardiomyopathy or ATTR-CM showed that switching from standard of care treatment and placebo to acoramidis increased serum transthyretin at the first month. The increase in serum transthyretin or TTR was correlated with reduced...
What's Going On With Cingulate Shares Recently?
What's Going On With Cingulate Shares Recently?
Sep 1, 2024
Cingulate Inc. ( CING ) shares are soaring Friday. Last week, the company announced a Precision Timed Release (PTR) technology, designed to enhance ADHD drug delivery. The company’s technology aims to improve the onset and efficacy of existing ADHD treatments. Zacks Small-Cap Research also issued a note with a $70 valuation on the stock earlier this week. Trading Volume: The stock...
Novavax Gets FDA Emergency Use Authorization for Updated COVID-19 Vaccine
Novavax Gets FDA Emergency Use Authorization for Updated COVID-19 Vaccine
Sep 1, 2024
03:16 PM EDT, 08/30/2024 (MT Newswires) -- Novavax ( NVAX ) got the US Food and Drug Administration's emergency use authorization for the updated COVID-19 vaccine designed to target current variants, including the Omicron JN.1 strain, the agency said Friday. The vaccine is authorized for individuals aged 12 and older, aiming to enhance protection against serious outcomes, including hospitalization and...
Soccer-Man Utd humbled as Diaz double helps Liverpool humiliate rivals
Soccer-Man Utd humbled as Diaz double helps Liverpool humiliate rivals
Sep 1, 2024
MANCHESTER, England, Sept 1 (Reuters) - Two goals from Luis Diaz and one from Mohamed Salah helped Liverpool stroll to a 3-0 victory at Manchester United ( MANU ) in the Premier League on Sunday, with Erik ten Hag's side humbled by their fierce rivals. Liverpool dominated a United team who could not keep pace with them in the first...
Copyright 2023-2026 - www.financetom.com All Rights Reserved